Hong Kong Island, Hong Kong, China The fund was located in Asia if to be more exact in Hong Kong. The main office of represented VC is situated in the Hong Kong.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Junson Capital, startups are often financed by YuanMing Capital, Viventures, Sinopharm Capital. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, StartX (Stanford-StartX Fund), South China Venture Capital.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
The overall number of key employees were 3.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ansun BioPharma, Apollomics, MultiVu Technologies. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Security, Medical. The fund has no exact preference in a number of founders of portfolio startups.
Related Funds
| Fund Name | Location |
| ADP | New Jersey, Roseland, United States |
| AION Capital Partners | India, Maharashtra, Mumbai |
| Black Coral Capital | Boston, Massachusetts, United States |
| Cisco Entrepreneurs in Residence | California, San Jose, United States |
| Enrico Investments | - |
| G-Bar Ventures | - |
| Guangyi Chenxin Touzi | China, Fujian, Xiamen |
| Idea Foundry | Pennsylvania, Pittsburgh, United States |
| Infinite Potential Group | - |
| KB Partners | Highland Park, Illinois, United States |
| Manresa Ventures | California, San Francisco, United States |
| Mey Capital Matrix | Bayern, Germany, München |
| Moonshots Capital | California, Los Angeles, United States |
| Muse Capital | - |
| QPDigital | Kyiv, Ukraine, Київська міська громада |
| Schechter Private Capital | - |
| Sempra Energy | California, San Diego, United States |
| Shin Kong Life Insurance | - |
| Tongxing Caifu | China, Jiangsu, Suzhou |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Full-Life Technologies | $47M | 03 Jan 2024 | Shanghai, Shanghai, China | ||
Corsair Pharma | $23M | 20 Sep 2023 | Sunnyvale, California, United States | ||
Worg Pharmaceuticals | $61M | 14 Sep 2022 | Shangcheng District, Zhejiang, China | ||
BridGene Biosciences | $38M | 27 Jul 2022 | Sunnyvale, California, United States | ||
Leo Cancer Care | $25M | 20 Jul 2021 | Surrey, England, United Kingdom | ||
| $30M | 18 Jan 2021 | Shangcheng District, Zhejiang, China | |||
WiBotic | $5M | 11 Jun 2020 | Seattle, Washington, United States | ||
RaySecur | $3M | 05 Dec 2019 | Cambridge, Massachusetts, United States | ||
| $100M | 15 Oct 2019 | San Diego, California, United States |
– Leo Cancer Care is a Horley, UK- and Middleton, Wisconsin-based radiation therapy startup.
– The company raised $25.3m in Series B funding.
– The round was led by Pureland Global Venture, Yu Galaxy, WARF, Alumni Ventures, Junson Capital and Serra Ventures as well as industry leaders CHC, Cosylab, Toret Devices and Radiation Business Solutions.
– The new investment will be used to expand their teams in the US, Europe and Singapore and continue the development of its upright radiotherapy solutions.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Full-Life Technologies | $47M | 03 Jan 2024 | Shanghai, Shanghai, China | ||
Corsair Pharma | $23M | 20 Sep 2023 | Sunnyvale, California, United States | ||
Worg Pharmaceuticals | $61M | 14 Sep 2022 | Shangcheng District, Zhejiang, China | ||
BridGene Biosciences | $38M | 27 Jul 2022 | Sunnyvale, California, United States | ||
Leo Cancer Care | $25M | 20 Jul 2021 | Surrey, England, United Kingdom | ||
| $30M | 18 Jan 2021 | Shangcheng District, Zhejiang, China | |||
WiBotic | $5M | 11 Jun 2020 | Seattle, Washington, United States | ||
RaySecur | $3M | 05 Dec 2019 | Cambridge, Massachusetts, United States | ||
| $100M | 15 Oct 2019 | San Diego, California, United States |
